… ProQR. “These results build confidence in QR-110 and the broader ability of oligonucleotides to improve vision in … an endogenously expressed RNA editing system called ADAR, which it can direct to the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is …
… an endogenously expressed RNA editing system called ADAR, which can direct the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is … decay (NMD) in a sequence-specific manner and promote PTC readthrough. The Trident ® technology has the potential to be …
… December 31, 2019 and provided a business update. “We made significant progress in 2019 as we advanced our … an endogenously expressed RNA editing system called ADAR, which can direct the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is …
… an endogenously expressed RNA editing system called ADAR, which can direct the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is … decay (NMD) in a sequence-specific manner and promote PTC readthrough. The TRIDENT ® technology has the potential to be …
… an endogenously expressed RNA editing system called ADAR, which can direct the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is … decay (NMD) in a sequence-specific manner and promote PTC readthrough. The TRIDENT technology has the potential to be …
… an endogenously expressed RNA editing system called ADAR, which can direct the change of an Adenosine (A) to an Inosine (I) in the RNA – an Inosine is … decay (NMD) in a sequence-specific manner and promote PTC readthrough. The TRIDENT technology has the potential to be …
… ® , which uses a cell’s own editing machinery called ADAR (adenosine deaminase acting on RNA) to make specific … the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including … +1 617 599 6228 skiely@proqr.com or Hans Vitzthum LifeSci Advisors T: +1 617 430 7578 hans@lifesciadvisors.com Media …
… ® , which uses a cell’s own editing machinery called ADAR (adenosine deaminase acting on RNA) to make specific … the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including … +1 617 599 6228 skiely@proqr.com or Hans Vitzthum LifeSci Advisors T: +1 617 430 7578 hans@lifesciadvisors.com Media …
… Axiomer®, which uses a cell’s own editing machinery called ADAR (adenosine deaminase acting on RNA) to make specific … the risks, uncertainties and other factors in our filings made with the Securities and Exchange Commission, including … +1 617 599 6228 skiely@proqr.com or Hans Vitzthum LifeSci Advisors T: +1 617 430 7578 hans@lifesciadvisors.com Media …
… All of the shares in the Offering were sold by ProQR. In addition, ProQR today announced the closing of its previously … Cantor, Raymond James and Oppenheimer & Co. acted as joint lead bookrunning managers for the Offering. A shelf … Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to …